Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Immunology | Genetic Disease
Amyloidosis Clinical Trials
A listing of Amyloidosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
California
Los Angeles : Cedars-Sinai Medical Center
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Orange : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
San Francisco : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Stanford : Stanford University
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Stanford : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Colorado
Aurora : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Florida
Weston : The Cleveland Clinic
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Illinois
Elgin : Sherman Health
ECOG E4A08: A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) versus Bortezomib, Melphalan, and Dexamethasone (BMDex) for Untreated Patients with Systemic Light-chain (AL) Amyloidosis Ineligible for Autologous Stem-cell Transplantation
View More »
Chicago : University of Chicago
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Chicago : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Oak Lawn : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Indiana
Indianapolis : Indiana University
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Indianapolis : IU Simon Cancer Center
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Maryland
Baltimore : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Bethesda : National Institute of Arthritis and Musculoskeletal and Skin Diseases
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Massachusetts
Boston : Boston Medical Center
A Phase I/II Trial of Pomalidomide and Dexamethasone in Subjects With Previously-Treated AL Amyloidosis
Boston : Boston Medical Center
Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis
Boston : Boston Medical Center
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Boston : Boston Medical Center HEM/ONCO
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Boston : Tufts Medical Center
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
View More »
Boston : Boston Medical Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Boston : Tufts Medical Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Boston : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Michigan
Detroit : Barbara Ann Karmanos Cancer Center
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Detroit : Barbara Ann Karmanos Cancer Institute
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Detroit : Karmanos Cancer Institute
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Minnesota
Rochester : Mayo Clinic
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Rochester : Mayo Clinic
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
New Jersey
Hackensack : John Theurer Cancer Center at Hackensack University Medical Center
A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
New York
New York : Columbia University
Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis
New York : Memorial Sloan-Kettering Cancer Center
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis
New York : Mount Sinai School of Medicine
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
New York : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Ohio
Cleveland : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Columbus : Ohio State University Medical Center
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Columbus : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Oregon
Portland : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Pennsylvania
Philadelphia : Abramson Cancer Center of Univ of Pennsylvania
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Philadelphia : Fox Chase Cancer Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Philadelphia : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Pittsburgh : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Wisconsin
Milwaukee : Froedtert & Medical College of Wisconsin
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Argentina
Buenos Aires : CEMIC
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Ciudad de Buenos Aires : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Sante Fe : Sanatorio Parque
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Australia
Nedlands : Sir Charles Gairdner Hospital
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Woolloongabba : Princess Alexandra Hospital
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Belgium
Leuven : UZ Leuven
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Leuven : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Brazil
Curitiba, Parana : Associação Paranaense De Cultura - APC / Hospital Universitário Cajuru da PUCPR
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Ilha do Fundao : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Sao Paulo : Hospital Santa Marcelina
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Bulgaria
Sofia : University Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski"
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Sofia : University Multiprofile Hospital for Active Treatment "Aleksandrovska"
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Canada
Calgary : Tom Baker Cancer Centre
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Toronto : University Health Network, Princess Margaret Hospital
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Vancouver : Vancouver General Hospital
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Chile
Santiago : Centro de Estudios Reumatológicos
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Cyprus
Nicosia : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Czech Republic
Praha 2 : Vseobecna fakultni nemocnice v Praze
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Denmark
Arhus N : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Egypt
Cairo : Ain Shams University Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Cairo : Al Hussain University Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Cairo : Sayed Galal University Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Finland
Helsinki : Helsingin yliopistollinen keskussairaala / Meilahti
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
France
Creteil : Hôpital Henri Mondor
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Créteil : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Le Kremlin-bicetre : Clinical Trial Site
Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis
Lille : Hôpital Claude Huriez
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Limoges : CHU Limoges
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
View More »
Marseille Cedex : Clinical Trial Site
Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis
Paris : Hôpital Tenon
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Toulouse Cedex9 : Hôpital de Rangueil
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Germany
Berlin : Charité Universitätsmedizin Berlin
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Hannover : KRH Klinikum Oststadt-Heidehaus
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Heidelberg : Universität Heidelberg
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Heidelberg : University Hospital, Amyloidosis Center Med.
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Heidelberg : University of Heidelberg
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
View More »
Heidelberg : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Munster : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
India
Jaipur : Dr. Mukesh Jain Clinic
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Kanpur : Regency Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Manipal : Kasturba Medical College
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Nadiad : Muljibhai Patel Urological Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
New Delhi : Sir Ganga Ram Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Israel
Haifa : Bnei Zion Medical Center
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Holon : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Ramat-Gan : The Chaim Sheba Medical Center
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Italy
Bologna : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Messina : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Modena : Azienda Ospedaliero-Universitaria di Modena Policlinico
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Pavia : IRCCS Policlinico San Matteo
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Pavia : Centro Amiloidosi Padiglione Forlanini - 3° Piano
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
View More »
Pavia : Amyloidosis Research & Treatment Center
Study of Oral MLN9708 in Adult Patients With Relapsed or Refractory Light Chain Amyloidosis
Pavia : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Reggio Emilia : Arcispedale Santa Maria Nuova
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Japan
Kumamoto : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Matsumoto : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Lithuania
Kaunas : Hospital of Lithuanian University of Health Sciences Kaunas Clinics
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Vilnius : Vilnius University Hospital Santariskiu Klinikos
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Mexico
Aguascalientes : Centenario Hospital Miguel Hidalgo
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Monterrey : Unidad Medica de Tratamientos Avanzados S.C.
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Tlalpan : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Netherlands
Amsterdam : VUMC Ams VUMC Amsterdam
Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis
Groningen : Universitair Medisch Centrum Groningen
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Groningen : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Maastricht : Academisch Ziekenhuis Maastricht
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Peru
Ica : Clinica Medica San Martin E.I.R.L
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Lima : Hospital Nacional Arzobispo Loayza
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Poland
Olsztyn : Wojewodzki Szpital Specjalistyczny
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Warszawa : ARS RHEUMATICA Sp. z o.o.
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Wroclaw : Akademicki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Portugal
Lisbon : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Lisbon : Clinical Trial Site
Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis
Porto : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Porto : Clinical Trial Site
Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis
Russian Federation
Ekaterinburg : Sverdlovsk Regional Clinical Hospital #1
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Kemerovo : Kemerovo State Medical Academy of Roszdrav
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Moscow : Institute of Rheumatology of RAMN
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Novosibirsk : Research Institute of Clinical and Experimental Lymphology
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
St. Petersburg : North-West State Medical University n.a. I.I. Mechnikov
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
View More »
Voronezh : Voronezh State Medical Academy n.a. N.N.Burdenko
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Spain
Barcelona : Hospital Clinic de Barcelona
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Barcelona : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Malaga : Hospital Civil Carlos Haya
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Monte Alegre, Ribeirão Preto : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Sweden
Stockholm : Karolinska Universitetssjukhuset i Huddinge
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Umea : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Umeå : Clinical Trial Site
Trial to Evaluate Safety and Tolerability of ALN-TTR02 in Transthyretin (TTR) Amyloidosis
Taiwan
Taipei : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Taipei City : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Tunisia
Monastir : Fattouma Bourguiba University Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Sfax : Hedi Chaker University Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Sousse : Sahloul Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Tunis : Hôpital Charles Nicolle
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Tunis : La Rabta Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Turkey
Adana : Cukurova University Medical Faculty Balcali Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Ankara : Hacettepe University Medical Faculty
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Eskisehir : Eskisehir Osmangazi University Medical Faculty
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Istanbul : Pfizer Investigational Site
Transthyretin-Associated Amyloidoses Outcome Survey (THAOS)
Ukraine
Donetsk : Municipal Medical & Preventive Institution Donetsk Regional Clinical Territorial Medical Association
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Donetsk : Municipal Treatment-Prophylactic Institution Central City Clinical Hospital #1
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Kyiv : National Scientific Center "Institute of cardiology n.a. academician M.D Strazhesko"
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Kyiv : State Institution "Institute of Nephrology of AMS of Ukraine"
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
United Kingdom
London : Royal Free Hospital
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
